U.K. Upholds One Lipitor Patent, Invalidates Another

Law360, New York (October 12, 2005, 12:00 AM EDT) -- In a decision that both pharmaceutical companies Pfizer and Ranbaxy plan to appeal, a U.K. court has upheld one of Pfizer’s patents for billion-dollar drug Lipitor and has ruled another invalid.

The decision comes as many wait for the outcome of a similar case between the two companies currently being tried in the United States.

Pfizer said the company was pleased with the decision, although it plans to appeal the invalidity ruling.

"This court decision is consistent with the fundamental principle that patent laws exist to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.